Yoğun Bakımda COVID-19 ve Akciğer Hastalıklarında Ayırıcı Tanı.
Özet
Bu çalışma, yoğun bakımda takip edilen COVID-19 hastalarında akciğerin enfeksiyöz ve enfeksiyon dışı hastalıkları ile yapılacak ayırıcı tanının önemini ve radyolojinin bu süreçteki rolünü ele almaktadır. COVID-19; ARDS, solunum yetmezliği ve tromboemboli gibi ağır klinik tablolarla seyredebilmekte, semptomlarının spesifik olmaması nedeniyle diğer akciğer patolojileriyle kolayca karışabilmektedir. Özellikle RT-PCR testinin negatif çıktığı ancak klinik şüphenin sürdüğü durumlarda doğru ayırıcı tanının yapılması hayati önem taşır. Enfeksiyöz nedenler arasında diğer solunumsal virüsler (influenza, MERS, SARS, RSV), atipik bakteriler, mantar enfeksiyonları ve tüberküloz yer alırken; enfeksiyon dışı nedenler arasında pulmoner tromboemboli, pulmoner ödem, hipersensivite pnömonisi, eozinofilik akciğer hastalıkları ve idiyopatik interstisyel pnömoniler öne çıkmaktadır. Tanı sürecinde toraks bilgisayarlı tomografisi (BT); buzlu cam dansiteleri, konsolidasyon, kaldırım taşı manzarası, halo ve ters halo gibi bulgularla tipik, şüpheli veya atipik tutulumları ayırt etmede ve olası komplikasyonları saptamada duyarlılığı yüksek bir kılavuz görevi üstlenir. Sonuç olarak, hastaların klinik özellikleri, semptom geçmişi, laboratuvar bulguları ve radyolojik evrelerinin bir bütün halinde, kronik hastalıklar ve maruziyetler de göz önünde bulundurularak değerlendirilmesi, yanlış veya geç tanıların önüne geçilmesinde kritik bir role sahiptir.
This study addresses the importance of differential diagnosis between COVID-19 and other infectious or non-infectious lung diseases in intensive care patients, highlighting the role of radiology in this process. COVID-19 can present with severe clinical conditions such as ARDS, respiratory failure, and thromboembolism, and its non-specific symptoms frequently overlap with other lung pathologies. Differential diagnosis is especially vital in cases where RT-PCR tests return negative but clinical suspicion persists. While infectious causes include other respiratory viruses (influenza, MERS, SARS, RSV), atypical bacteria, fungal infections, and tuberculosis; non-infectious causes prominently feature pulmonary thromboembolism, pulmonary edema, hypersensitivity pneumonitis, eosinophilic lung diseases, and idiopathic interstitial pneumonias. During the diagnostic process, chest computed tomography (CT) serves as a highly sensitive guide in identifying typical, indeterminate, or atypical involvements and detecting complications through key patterns such as ground-glass opacities, consolidation, crazy-paving, halo, and reverse halo signs. In conclusion, evaluating patients' clinical features, symptom timeline, laboratory findings, and radiological stages as a whole—while also considering chronic diseases and exposures—plays a critical role in preventing misdiagnoses or diagnostic delays.
Referanslar
He F, Deng Y, Li W. Coronavirüs disease 2019: What we know? J Med Virol. 2020 Mar 14. doi: 10.1002/jmv.25766.
Bordi L, Nicastri E, Scorzolini L, et al. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Euro Surveill. 2020 Feb 27;25(8):2000170. doi: 10.2807/1560-7917.ES.2020.25.8.2000170
Ribeiro da silva SJ, Alves da Silva TA, Guarines KM. Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19. ACS Infect Dis. 2020 Aug 4:acsinfecdis.0c00274. doi: 10.1021/acsinfecdis.0c00274.
Jain S, Self WH, Wunderink RG, et all Study Team . Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27.
Alimi Y, Lim WS, Lansbury L et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol. 2017 Oct; 95:26-35. Doi: 10.1016/j.jcv.2017.07.019.
Wu X, Wang Q, Wang M et al. Incidence of respiratory viral infections detected by PCR and real-time PCR in adult patients with community-acquired pneumonia: a meta-analysis. Respiration 2015; 89(4): 343-352. doi: 10.1159/000369561
Researchgate (2019). Viral Pnömoniler. (30.01.2022 tarihinde https://www.researchgate.net/publication/350837494 adresinden ulaşılmıştır._)
Sangil A, Calbo E, Robles A, Benet S, Viladot ME, Pascual V, et al. Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses. Eur J Clin Microbiol Infect Dis 2012; 31: 2765-72
Alkan Çeviker S, Dindar Demiray EK. SARS-CoV-2 (COVİD 19) Enfeksiyonu Ayırıcı Tanı Açısından Diğer Solunumsal Virüsler. J Biotechnol and Strategic Health Res. 2020;1(Özel Sayı):45-49 doi:10.34084/bshr.714383
Petrosillo N, Viceconte G, Ergonul O, et al. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020; 26(6):729-734. Doi:10.1016/j.cmi.2020.03.026
Cozzi D, Bicci E, Bindi A, et al. Role of Chest Imaging in Viral Lung Diseases. Int J Environ Res Public Health. 2021 Jun 18(12):6434.
Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019;23(1):258. doi:10.1186/s13054-019-2539-x
Erdoğan M, Savaş R. (2021). Viral Pnömoni Tanısında Radyoloi. Yılmaz Bülbül, Celal Kurtuluş Buruk, Özlem Erçen Diken (Eds.), Viral Pnömoniler (s.89-99). Ankara: Dünya Tıp Kitapevi
Lin L, Fu G, Chen S et al. CT Manifestations of Coronavirus Disease (COVID-19) Pneumonia and Influenza Virus Pneumonia: A Comparative Study. AJR Am J Roentgenol. 2021 Jan; 216(1):71-79. doi: 10.2214/AJR.20.23304.
Ruuskanen O, Lahti E, Jennings LC et al. Viral pneumonia. Lancet. 2011; 377(9773):1264-75. doi: 10.1016/S0140-6736(10)61459-6.
Walsh E.E, Peterson D.R, Falsey A.R. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible? J. Infect Dis. 2007;195(7):1046-51. doi: 10.1086/511986.
Stefanidis K, Konstantelou E, Timothy Y, et al. Radiological, epidemiological and clinical patterns of pulmonary viral infections. Eur J Radiol. 2021;136:109548. doi: 10.1016/j.ejrad.2021.109548.
Le Balc'h P, Pinceaux K, Pronier C, Herpes et al. Simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care. 2020 28; 24(1):530.
Xu R, Zhou Y, Cai L et al. Co‐Reactivation of Human Herpesvirus alpha Subfamily (HSV Ⅰ and VZV) in Critically Ill Patient with COVID‐19. Br J Dermatol. 2020; 183(6):1145-1147
Alanezi M. Varicella pneumonia in adults: 13 years' experience with review of literature. Ann Thorac Med. 2007; 2(4):163-5.
Franquet T. Imaging of pulmonary viral pneumonia. Radyoloji. 2011;260(1):18-39. doi: 10.1148/radiol.11092149.
Chen S, Zhu O, Xiao Y et al. Clinical and etiological analysis of co‐infections and secondary infections in COVID‐19 patients: An observational study. 2021;15(7):815-825. doi: 10.1111/crj.13369.
Musuuza JS, Watson L, Parmasad V, et al. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. Plos One 2021;16(5):e0251170. doi: 10.1371/journal.pone.0251170.
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA 323(20), 2052–2059. doi: 10.1001/jama.2020.6775.
Goel N , Ahmad R , Fatma H , et al. New threatening of SARS-CoV-2 coinfection and strategies to fight the current pandemic. Med Drug Discov. 2021;10:100089. doi: 10.1016/j.medidd.2021.100089.
Küpeli E. (2017). Atipik Pnömoniler. Nazan Şen, Mustafa Hikmet Özhan (Eds.), Pnömoni (s.83-109). Tüsad Eğitim Kitapları Serisi.
StatPearls (2021). Mycoplasma Pneumonia. (01.02.2022 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK430780/ adresinden ulaşılmıştır.)
StatPearls (2021). Klamidya Pnömonisi. (01.02.2022 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK560874/ adresinden ulaşılmıştır.)
StatPearls (2021). Legionnaires' Disease. (01.02.2022 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK430807 adresinden ulaşılmıştır.)
Peman J, Ruiz-Gaitan A, Garcia-Vidal C, et al. Fungal co-infection in COVID-19 patients: Should we be concerned? Rev Iberoam Micol. 2020; 37(2):41-46. doi: 10.1016/j.riam.2020.07.001
Bretagne S, Sitbon K, Bottorel F, et al. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave. Microbiol Spectr. 2021;9(2):e01138-21. doi: 10.1128/Spectrum.01138-21.
John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel) 2021; 7 (4):298. doi: 10.3390/jof7040298.
Al-Hatmi AMS, Mohsin J, Al-Huraizi A, et al. COVID-19 associated invasive candidiasis. J Infect. 2021 Feb; 82(2):e45-e46. doi: 10.1016/j.jinf.2020.08.005.
Alanio A, Delliere s, Voicu S, et al. The presence of Pneumocystis jirovecii in critically ill patients with COVID-19. J Infect. 2021; 82(4):84-123. doi: 10.1016/j.jinf.2020.10.034
Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1
Bartoletti M, Pascale R, Cricca M. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa1065.
Singh AK, Singh R, Joshi SR, et al. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021 Jul-Aug; 15(4):102146. doi: 10.1016/j.dsx.2021.05.019
Arastehfar A, Carvalho A, Nguyen MH, et al. COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions? J Fungi (Basel). 2020 Oct 8; 6(4): 211. doi: 10.3390/jof6040211
Chong WH, Saha BK, Chopra A. Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization? Infection. 2021 Dec;49(6):1079-1090. doi: 10.1007/s15010-021-01630-9.
Viceconte G, Buonomo AR, Lanzardo A, et al. Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19. Infec Dis. (Lond). 2021;53(5):382–385. doi: 10.1080/23744235.2021.1890331.
Kelly S, Waters L, Cevik M, et al. Pneumocystis pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19. Clin Med (Lond) 2020;20(6):590–592. doi: 10.7861/clinmed.2020-0565.
Barben J, Quipourt V, Vovelle J, et al. Not COVID-19, don’t overlook pneumocystis in patients on gefitinib! Curr Oncol. 2021;28(1):961–4. doi: 10.3390/curroncol28010094
Yao Z, Chen J, Wang Q, et al. . Three patients with COVID-19 and pulmonary tuberculosis, Wuhan, China, January–February 2020. Emerg Infect Dis. (2020) 26:2754. Doi:10.3201/eid2611.201536
TB/COVID-19 Global Study Group. Tuberculosis and COVID-19 co-infection: description of the global cohort. Eur Respir J 2021 Nov 11;2102538. doi: 10.1183/13993003.02538-2021.
Kwee R.M, Adams H.J.A, Kwee T.C. Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis. Eur Radiol. 2021 May 9: 1-19. doi: 10.1007/s00330-021-08003-8
Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3.
Whyte MB, Kelly PA, Gonzalez E, et al. Pulmonary embolism in hospitalised patients with COVID-19. Thromb Res. 2020 Nov;195:95-99. doi: 10.1016/j.thromres.2020.07.025
Leonard-Lorant I, Delabrache X, Severac F, et al. BT anjiyografide COVID-19 hastalarında akut pulmoner emboli ve d-dimer seviyeleri ile ilişkisi. Radyoloji. 2020; 296 :E189–E191. doi: 10.1148/radiol.2020201561
Gervaise A, Bouzad C, Peroux E, et al. Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department. Eur Radiol. 2020 Nov;30(11):6170-6177. doi: 10.1007/s00330-020-06977-5.
Kasapoğlu US, Gök A, Acun Delen L, et al. Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. Tuberk Toraks. 2021;69(2):177-186. doi: 10.5578/tt.20219807.
Wielandner A, Agarwal P, Toelly A, et al. Noninfectious differential diagnoses of pneumonia. Radiologe 2017;57(1):35-42. doi:10.1007/s00117-016-0196-5.
Surbhi S, Singh Y, Soni K.D, et al. Proteinaceous Lung With COVID-19: The Mimicker. Cureus. 2021; Sep; 13(9): e18144. doi: 10.7759/cureus.18144
Hanfi SH, Lalani TK, Saghir A, et al. COVID-19 and its Mimics What the Radiologist Needs to Know. J Thorac Imaging. 2021;36(1): W1–W10. doi: 10.1097/RTI.0000000000000554.
Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 ;202(3):e36-e69. doi: 10.1164/rccm.202005-2032ST
Shimoda M, Morimoto K, Tanaka Y, et al. Increase in humidifier lung cases owing to coronavirus disease. Respir Investig. 2021 Sep;59(5):706-707. doi: 10.1016/j.resinv.2021.05.013.
Travis WD, Costabel U, Hansell DM. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48. doi: 10.1164/rccm.201308-1483ST.
Guarnera A, Santini E, Podda P. Idiopathic Interstitial Pneumonias and COVID-19 Pneumonia: Review of the Main Radiological Features and Differential Diagnosis Tomography. 2021 Aug 31;7(3):397-411. doi: 10.3390/tomography7030035.
Hobbs S, Lynch D. The idiopathic interstitial pneumonias: an update and review. Radiol Clin North Am. 2014 Jan;52(1):105-20. doi: 10.1016/j.rcl.2013.08.001.
Rendeki S, Molnar T.F. Pulmonary contusion. J Thorac Dis. 2019 Feb; 11(Suppl 2):S141-S151. doi: 10.21037/jtd.2018.11.53.
Bekci T, Aslan S, Cakir IM. COVID- 19 pneumonia misdiagnosed as pulmonary contusion in a child. Br J Hosp Med (Lond). 2020;81(5):1. doi: 10.12968/hmed.2020.0224.
Sevinç, C. (2016). Aspirasyon Pnömonisi ve Yatağa Bağımlı Hastada İnfeksiyondan Korunma. Nazan Şen, Mustafa Hikmet Özhan (Eds.), Pnömoni (167-176). Ankara: 2017
Xu Y, Liu H, Hu K, et al. Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19). Zhongguo Fei ai Za Zhi 2020;23(3):136-41. doi: 10.3779/j.issn.1009-3419.2020.03.02
Adams HJA, Kwee TC, Yakar D, et al. Systematic Review and Meta Analysis on the Value of Chest CT in the Diagnosis of Coronavirus Disease (COVİD-19): Sol Scientiae, Illustra Nos. AJR Am J Roentgenol. 2020;215(6):1342-50. doi: 10.2214/AJR.20.23391
Pan F, Ye T, Sun P, et al. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology, 2020; 295 :715–721. doi: 10.1148/radiol.2020200370.
Ye Z, Zhang Y, Wang Y, et al. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020 Aug;30(8):4381-4389. doi: 10.1007/s00330-020-06801-0.
Hani C, Trieu NH, Saab I, et al. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis. Diagn Interv Imaging. 2020 May;101(5):263-268. doi: 10.1016/j.diii.2020.03.014.
Revel MP, Parkar AP, Prosch H, et al. COVID-19 patients and the radiology department - advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Eur Radiol. 2020 Sep;30(9):4903-4909. doi: 10.1007/s00330-020-06865-y.
Yavuz B, Aydin N, An Overview of the Chest Computed Tomography Manifestations for Coronavirus Disease(COVID-19), Osmangazi Journal of Medicine, 2021, doi: 10.20515/otd.847993
Ufuk F, savaş R. Chest CT features of the novel coronavirus disease (COVID-19). Turk J Med Sci. 2020; 50(4): 664–678. doi: 10.3906/sag-2004-331
Roshkovan L, Chatterjee N, Galperin-aizenberg M, et al. The Role of Imaging in the Management of Suspected or Known COVID-19 Pneumonia. A Multidisciplinary Perspective. Annals of the American Thoracic Society. 2020 Nov;17(11):1358-1365. doi: 10.1513/AnnalsATS.202006-600FR.
